Emmaus Life Sciences
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Emmaus Life Sciences generated cash of -$1,503,000, which is more than the previous year. Cash used in financing activities reached the amount of $2,477,000 last year. Net change in cash is therefore $526,000.

Cash Flow

Emmaus Life Sciences, Inc. (OTC:EMMA): Cash Flow
2014 -3.27M -64.19K 3.33M
2015 -2.11M 1.5K 1.34M
2016 -2.97M -82.3K 2.94M
2017 -4.79M -479.5K 10.40M
2018 -9.03M -361.8K 7.20M
2019 -4.52M -1.48M 3.88M
2020 -2.45M 5.47M -2.31M
2021 -1.25M -6.37M 7.41M
2022 -5.07M -2.38M 7.23M
2023 -1.50M -432K 2.47M

EMMA Cash Flow Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Cash at beginning of period
2.02M2.27M2.48M1.76M3.90M5.44M318.2K432.1K1.24M1.27M
Operating activities
Net income
-3.73M-10.62M-15.94M1.1M-54.84M-10.33M-7.11M-5.94M-3.37M-2.66M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
32K53K59K60K73K117.9K48.7K7.2K7.6K10.3K
Stock-based compensation expense
1.26M16K553K739K3.80M02.08M758.4K241.7K1.00M
Deferred income tax benefit 1.26M16K553K739K3.80M02.08M758.4K241.7K1.00M
Changes in operating assets and liabilities:
Accounts receivable, net
-5.14M607K-845K1.95M-361K-500-1.4K6.7K-2.5K17.3K
Inventories
650K434K462K-245K-3.26M-91.5K-517.07K52.28K31.25K-19.23K
Accounts payable
4.8M3.67M2.52M-3.34M4.32M-432.7K301.5K-182.9K-15.8K0
Cash generated by operating activities
-1.50M-5.07M-1.25M-2.45M-4.52M-9.03M-4.79M-2.97M-2.11M-3.27M
Investing activities
Purchases Of Investments
0-5.28M-6.30M-30.11M1.64M0-190K000
Investments In Property Plant And Equipment
-17K-26K-73K-26.17M-60K-55.2K-130K-82.3K-4.73K-64.19K
Acquisitions Net
05.28M030.11M-1.64M-306.6K-190K01.5K0
Cash generated by investing activities
-432K-2.38M-6.37M5.47M-1.48M-361.8K-479.5K-82.3K1.5K-64.19K
Financing activities
Common Stock Issued
000142K8.58M930.43K10.46M001.69M
Payments for dividends
0000000000
Repurchases of common stock
00000-11.26M000-377.5K
Repayments of term debt
2.47M7.23M-8.77M-5.21M-4.89M-75.8K-57.4K-3.2K1.34M-7.2K
Cash used in financing activities
2.47M7.23M7.41M-2.31M3.88M7.20M10.40M2.94M1.34M3.33M
Net Change In Cash
526K-258K-208K718K-2.13M-2.19M5.13M-113.9K-808.5K-33K
Cash at end of period
2.54M2.02M2.27M2.48M1.76M3.25M5.44M318.2K432.1K1.24M
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source